Bioanalytical services

Inoviem can develop assays to measure the uptake of your compound in a human or animal matrix. 
Through our capabilities, notably LC-MS/MS and expertise in immunoassays, we are able to develop and pre-validate methods, according to ICHQ2 guidelines.

As we are not subject to GLP and GCP, we can develop and pre-validate methods at a lower cost than laboratories operating within these environments. While saving on costs, you can be confident of a method validation by a CRO working under GLP/GCP environment.

Pharmaco Kinetics

Inoviem is able to develop a LC-MS/MS assay or Immunoassays to measure the uptake of your compound in a human or animal matrix.

Pharmaco Dynamics

Inoviem can also develop a LC-MS/MS assay or Immunoassays to measure biomarkers and molecules of interest in a human or animal matrix.

Anti-Drug Antibody Assay (ADA)

You can request Inoviem to develop an assay to quantify and identify Anti-drug Antibodies which can appear naturally if your compound generates an immune system response.

Receptor Occupancy

Inoviem’s offer also includes developing a FACS assay to quantify and characterize the binding profile of your drugs.

Understand the Mode of Action of your compound

Identify and validate targets

Choose your lead compound for development

Stratify different patient groups

Define the indication

Identify biomarkers

Bioanalytical services

Need Help